CLINICAL TRIALS BY STATE
12+ recruiting studies in Montana, updated in real time and displayed in plain English.
BROWSE BY CONDITION IN MONTANA
RECRUITING TRIALS IN MONTANA
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
The PRIME Study: A Randomized, Controlled, Prospective Study
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
COMMON QUESTIONS
How many clinical trials are available in Montana?
There are currently 12+ recruiting clinical trials in Montana listed on ClinicalTrials.gov. Clinicals AI makes these easier to browse with plain-language summaries and condition filters.
How do I join a clinical trial in Montana?
Browse the listings above, review eligibility criteria, and submit a contact request. A study coordinator will follow up to discuss your eligibility and next steps.
Are clinical trials in Montana free?
Most trials cover the investigational treatment and study-related visits at no cost. Some also offer compensation for time and travel. Confirm cost details with each trial coordinator.
What conditions have trials in Montana?
Montana hosts trials across cancer, cardiovascular disease, diabetes, neurological conditions, mental health, autoimmune disease, and rare conditions. Browse by condition using the links above.